Importantly, inhibition of miR-21 can resensitize HCC cells to chemotherapeutics: in one study, an anti-miR-21 combined with sorafenib or doxorubicin produced greater tumor reduction than chemotherapy alone, likely by upregulating PTEN and other mediators of drug response [116]. Here, PTEN is linked to hepatocellular carcinoma.